Login Register
icon_bulk_orderBulk order Acrobiosystems for ChineseChinese
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
SARS-CoV-2 Delta | Claudin 18.2 | CD20 | CD133 | GPRC5D | CCR8 | CCR5 
0
There is no goods in the shopping cart !
My Cart
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Recombinant Proteins & Antibodies

  • Multi-pass Transmembrane Proteins and Technology Platforms
  • SARS-CoV-2 Related Kit Products
  • SPR /BLI analytical service
  • VEGF: Cutting off tumor\'s feeding channel
COVID-19 R&D

Accelerated Progress: Spike Protein Mutations on B.1.617 Identified and Studied

ACROBiosystems makes donations to BEI Resources, accelerating the process of attacking SARS-CoV-2 variants globally

The B.1.617 is Likely Behind the Recent Surge of COVID-19 Cases in India

The importance of N protein variants in antibody test and drug design

Reagents for vaccine development

ACROBiosystems has developed a series of critical reagents for COVID-19 vaccine development and evaluation,including proteins, antibodies and kits. These featured products are suitable for IgG/M antibody titer detection, neutralizing antibody titer detection and antigen titer detection.

SARS-CoV-2 proteins&kits

High quality SARS-CoV-2 S protein, S1 protein and human ACE2 protein based on the human cell expression platform of HEK293.

Reagents for COVID-19 diagnostics

ACROBiosystems has developed a serial of high-quality antigen and antibody reagents, including super stable trimeric S protein, S RBD, S1, S2, N proteins mainly expressed by HEK 293 and paired antibodies with outstanding sensitivity verified by inactivated virus samples.

SARS-CoV-2 Related Kit Products

ACROBiosystems has developed a series of kit products using its high-quality SARS-CoV-2 antigen proteins to improve the efficiency of anti-SARS-CoV-2 drugs and vaccines development.

Immune Checkpoint Proteins

ACROBiosystems has developed an exclusive immune checkpoint protein collection， The consistency and excellent performance of our proteins are confirmed by a variety of assays.

CD3 Proteins

ACROBiosystems has developed a series of homogeneous CD3 proteins with good bioactivity. They are verified as 1:1 heterodimers by nonreductive electrophoresis and MALS as well.

Fc Receptor Proteins

ACROBiosystems offers a comprehensive collection of recombinant Fc receptor proteins, including their common variants, to help expedite your mAb development.

Targets for ADCs

ACROBiosystems has developed a series of products with different species and tags for a variety of hot targets. It is suitable for immune, antibody screening, SPR, cell activity detection and other experiments, and all SPR&BLI protocols are available for free.

PE-labeled protein

ACROBiosystems has developed an exclusive collection of PE-labeled proteins by a proprietary site-specific conjugation technology, and these proteins are ideal for detecting CAR expression.

MABSOL® Biotinylated Proteins

The Mabsol biotinylated protein collection includes more than a hundred commonly studied drug targets and biomarker proteins.

Full-length Multi-pass Transmembrane Proteins

We supply full-length multi-pass TPs with stabilized structure and high activity including CD20, Claudin18.2, CD133, GPRC5D, CCR5 and CCR8, which can be used in immunization, ELISA, SPR, BLI, cell experiment and CAR detection.

Targets of CAR-T Cell Therapy

We also supply difficult-to-express proteins such as BCMA, CD19, ROR1, and EGFRVIII.                     

Newly Added Products

Mutants from SARS-CoV-2 Emerging Variants (Delta and more)

ACROBiosystems are going full steam ahead on developing a collection of recombinant antigens for emergency SARS-CoV-2 variants. The reagents can be used to evaluate the efficacy of the antibodies and vaccination.

Learn more

Full-length Multi-pass Transmembrane Proteins

We supply full-length multi-pass TPs with stabilized structure and high activity including CD20, Claudin18.2, CD133, GPRC5D, CCR5 and CCR8, which can be used in immunization, ELISA, SPR, BLI, cell experiment and CAR detection.

Learn more

News Center

The Top Risk of CAR-T Therapy: Cytokine Release Syndrome (CRS) ——Assessment, grading and management of CRS
2021/02/02
The Top Risk of CAR-T Therapy: Cytokine Release Syndrome (CRS) ——Assessment, grading and management of CRS
In recent years, CAR-T cell therapy brings the hope of a cure to many cancer patients. Despite the outstanding effectiveness, the toxicity called cytokine release syndrome (CRS) is a severe problem.
Learn more
Accelerated Progress: Spike Protein Mutations on B.1.617 Identified and Studied
2021/05/11
Accelerated Progress: Spike Protein Mutations on B.1.617 Identified and Studied
After the sharp rise in COVID-19 cases and deaths in India over recent weeks, at least 20 countries have imposed travel bans and restrictions to and from India. The world again stands at a crossroad of the viral evolution.
Learn more
ACROBiosystems makes donations to BEI Resources, accelerating the process of attacking SARS-CoV-2 variants globally
2021/05/10
ACROBiosystems makes donations to BEI Resources, accelerating the process of attacking SARS-CoV-2 variants globally
Multiple SARS-CoV-2 variants are emerging and circulating globally; the battle against COVID-19 pandemic is still challenging. Recently, ACROBiosystems donated SARS-CoV-2 mutant proteins to BEI Resources, a NIAID funded bioresource program, joining in the collective effort in attacking SARS-CoV-2 va
Learn more
The 4th Annual Sanofi Global Analytical Symposium
2021/06/15 - 2021/06/16
The 4th Annual Sanofi Global Analytical Symposium
Speaker: Prajwal Paudel and more
Time: JUNE 15-16.2021
Learn more

This web search service is supported by Google Inc.

totop
Call us
Call us
North America: +1 800-810-0816 (Toll Free)
Asia & Pacific: +86 400-682-2521
Email
Email
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook

Leave a message

Copyright © 2017 ACROBiosystems. All Rights Reserved
中文网站|Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap